Literature DB >> 26195808

Pharmacokinetic and pharmacodynamic properties of gamithromycin in turkey poults with respect to Ornithobacterium rhinotracheale.

Anneleen Watteyn1, Mathias Devreese2, Siegrid De Baere2, Heidi Wyns2, Elke Plessers2, Filip Boyen3, Freddy Haesebrouck3, Patrick De Backer2, Siska Croubels2.   

Abstract

The macrolide gamithromycin (GAM) has the ability to accumulate in tissues of the respiratory tract. Consequently, GAM might be a suitable antibiotic to treat bacterial respiratory infections in poultry, such as Ornithobacterium rhinotracheale. As O. rhinotracheale infections are common in turkey flocks, the aim of this study was to determine the pharmacokinetic (PK) parameters of GAM in plasma, lung tissue, and pulmonary epithelial lining fluid (PELF) of turkeys and to correlate them with pharmacodynamic (PD) characteristics (PK/PD). The animal experiment was performed with 64 turkeys, which received either a subcutaneous (SC, n=32) or an oral (PO, n=32) bolus of 6 mg GAM/kg body weight (BW). GAM concentrations in plasma, lung tissue, and PELF were measured at different time points post administration (p.a.), and PK characteristics were determined using non-compartmental modeling. The maximum plasma concentration after PO administration was ten-fold lower than after SC injection (0.087 and 0.89 μg/mL, respectively), whereas there was no difference in lung concentrations between both routes of administration. However, lung concentrations at day 1 p.a. were significantly higher than plasma levels for both routes of administration (2.22 and 3.66 μg/g for PO and SC, respectively). Consequently, lung/plasma ratios were high, up to 50 and 80 after PO and SC administration, respectively. GAM could not be detected in PELF, although this might be attributed to the collection method of PELF in birds. The GAM minimum inhibitory concentration (MIC) was determined for 38 O. rhinotracheale strains; MIC50 and MIC90 were 2 and >32 μg/mL, respectively. PK/PD correlation for lung tissue demonstrated that the time above the MIC90 of the susceptible population (2 μg/mL) was 1 day after PO bolus and 3.5 days after SC administration. The area under the curve (AUClast)/MIC ratios for lung tissue after SC and PO administration were 233 and 90, respectively. To conclude, GAM is highly distributed to lung tissue in turkey poults, suggesting that it has the potential to be used to treat respiratory infections such as O. rhinotracheale.
© 2015 Poultry Science Association Inc.

Entities:  

Keywords:  Ornithobacterium rhinotracheale; gamithromycin; pharmacodynamic; pharmacokinetic; turkey poult

Mesh:

Substances:

Year:  2015        PMID: 26195808     DOI: 10.3382/ps/pev217

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  3 in total

1.  Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model.

Authors:  Qingwen Yang; Xuesong Liu; Chenghuan Zhang; Kang Yong; Alancia Carol Clifton; Huanzhong Ding; Yun Liu
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

2.  Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against Streptococcus suis in Piglets.

Authors:  Rui-Ling Wang; Ping Liu; Xiao-Feng Chen; Xin Yao; Xiao-Ping Liao; Ya-Hong Liu; Jian Sun; Yu-Feng Zhou
Journal:  Front Vet Sci       Date:  2022-07-11

3.  Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease.

Authors:  Dietmar Hamel; Alexandra Richard-Mazet; Florian Voisin; Inge Böhne; Florence Fraisse; Renate Rauh; Rose Huang; Michael Kellermann; Laura Letendre; Pascal Dumont; Steffen Rehbein
Journal:  Vet Med Sci       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.